Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview
Alexandre Chan(University of California, Irvine), Maryam B. Lustberg(Yale Cancer Center), Charles L. Loprinzi(Mayo Clinic in Arizona), Chia Jie Tan(University of Utah), Ishwaria M. Subbiah(The University of Texas MD Anderson Cancer Center), Andreas S. Beutler(Mayo Clinic), Kord M. Kober(University of California, San Francisco), C Dumitrescu(Marie Curie), Jayesh Kamath(University of Connecticut), Manuel Morales‐Ruiz(Universitat de Barcelona), Margherita Gobbo(University of Trieste), Katherine B. Peters(Haukeland University Hospital), Samantha Mayo(University of Toronto), Daniel L. Hertz(GTx (United States)), James D’Olimpio(Northwell Health), Nathan P. Staff(Mayo Clinic), Shivani Shinde(Intermountain Healthcare), Elizabeth Adams(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Sharon M. Gordon(University of Maryland, Baltimore), Jeong Hoon Oh(The University of Texas MD Anderson Cancer Center), Doreen Pon(Western University of Health Sciences), Linda Pang(Kelsey-Seybold Clinic), Niharkia Dixit(San Francisco General Hospital)
Cited by 79
Related Papers
Monitoring Sedation Status Over Time in ICU Patients
|JAMA|2003|1.7k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
|Journal of the American College of Cardiology|2013|631